Detalhe da pesquisa
1.
Development and Independent Validation of a Prognostic Gene Expression Signature Based on RB1, PTEN, and TP53 in Metastatic Hormone-sensitive Prostate Cancer Patients.
Eur Urol Oncol
; 2024 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38429210
2.
Transcriptional Profile Associated with Clinical Outcomes in Metastatic Hormone-Sensitive Prostate Cancer Treated with Androgen Deprivation and Docetaxel.
Cancers (Basel)
; 14(19)2022 Sep 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-36230681